Related references
Note: Only part of the references are listed.Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy
Khaled Ghattass et al.
CURRENT CANCER DRUG TARGETS (2013)
The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression
Kotaro Miyake et al.
EXPERIMENTAL CELL RESEARCH (2012)
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
Carmen Chak-Lui Wong et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer
Luciana P. Schwab et al.
BREAST CANCER RESEARCH (2012)
Rapid non-genomic signalling by 17β-oestradiol through c-Src involves mTOR-dependent expression of HIF-1α in breast cancer cells
S. Sudhagar et al.
BRITISH JOURNAL OF CANCER (2011)
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004-2010)
Hyun Seung Ban et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Gene expression and hypoxia in breast cancer
Elena Favaro et al.
GENOME MEDICINE (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
J. Chen et al.
BRITISH JOURNAL OF CANCER (2010)
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21
Mona El-Khatib et al.
RADIATION ONCOLOGY (2010)
Cancer stem cells at the crossroads of current cancer therapy failures Radiation oncology perspective
Ulrike Koch et al.
SEMINARS IN CANCER BIOLOGY (2010)
The tumor microenvironment and metastatic disease
Sarah Jane Lunt et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells
Joelle Haykal et al.
RADIATION ONCOLOGY (2009)
Cancer Stem Cells, Hypoxia and Metastasis
Richard P. Hill et al.
SEMINARS IN RADIATION ONCOLOGY (2009)
The novel hypoxic cell radio sensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer
Kotaro Miyake et al.
CANCER LETTERS (2008)
Targeting tumour hypoxia in breast cancer
Manuela Milani et al.
EUROPEAN JOURNAL OF CANCER (2008)
Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation
Mei Yee Koh et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Hypoxia-driven selection of the metastatic phenotype
Richard Sullivan et al.
CANCER AND METASTASIS REVIEWS (2007)
Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer
Alshad S. Lalani et al.
CLINICAL CANCER RESEARCH (2007)
Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells
Wafica Itani et al.
RADIATION ONCOLOGY (2007)
Differentiation arrest by hypoxia
Qun Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antianglogenic potential of the mammalian target of rapamycin inhibitor temsirolimus
Donatella Del Bufalo et al.
CANCER RESEARCH (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells
S Harakeh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2004)
DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1α in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
M Kaluzová et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Quinoxaline 1,4-dioxides: Hypoxia-selective therapeutic agents
M Diab-Assef et al.
MOLECULAR CARCINOGENESIS (2002)
HIF-1 and mechanisms of hypoxia sensing
GL Semenza
CURRENT OPINION IN CELL BIOLOGY (2001)
Share Paper
